Back

Circulating MicroRNA profile in coronary artery disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Emerging biomarkers and molecular mechanisms in cardiovascular disease: from inflammation to remodelling Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Sumit Kumar

All India Institute of Medical Sciences AIIMS New Delhi, New Delhi (India)

6 More presentations in this session

Presentation thumbnail
Discussant - Emerging biomarkers and molecular mechanisms in cardiovascular disease: from inflammation to remodelling
Presentation thumbnail
Raised high sensitivity Troponin T (Hs-TnT) assays in non-ACS medical admissions and long term outcomes
Doctor S. Mckittrick (Castlebar, IE)
Abstract Slides Video
Presentation thumbnail
The product of bilirubin and trigliseride is the most significant predictor of severe FIB-4 index of liver disease in cardiac patients
Doctor S. Celik (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Association of interleukin gene polymorphisms with coronary artery disease severity
Miss M. Liu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Troponin elevation and vascular involvement post-COVID-19
Doctor A. Kamdar (Glasgow, GB)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Emerging biomarkers and molecular mechanisms in cardiovascular disease: from inflammation to remodelling

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Circulating microRNA signatures are associated with epicardial coronary dysfunction in patients underwent invasive physiological evaluation: The ANFIBIO Study
thumbnail
Congress Presentation
MicroRNA signatures in diabetes and myocardial infarction: in silico prediction and bench-to-bedside analysis
thumbnail
Congress Presentation
A specific molecular signature of extra-vesicles (EVs) was associated with cardiometabolic risk profile and atherosclerotic burden in patients with chronic coronary syndrome: a pilot study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources